Novozymes (NVZMY)
(Delayed Data from OTC)
$55.76 USD
+0.41 (0.74%)
Updated Apr 26, 2024 03:59 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NVZMY 55.76 +0.41(0.74%)
Will NVZMY be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for NVZMY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVZMY
MATV vs. NVZMY: Which Stock Should Value Investors Buy Now?
Is CalMaine Foods (CALM) Stock Outpacing Its Basic Materials Peers This Year?
NVZMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
MATV or NVZMY: Which Is the Better Value Stock Right Now?
Are Basic Materials Stocks Lagging Novozymes (NVZMY) This Year?
MATV vs. NVZMY: Which Stock Is the Better Value Option?
Other News for NVZMY
DNB Markets gets more bullish on Novonesis, upgrades shares
Warning: NVZMY is at high risk of cutting its dividend
Novonesis price target raised by DKK 60 at Berenberg
Novonesis price target raised by DKK 50 at Barclays
Warning: NVZMY is at high risk of cutting its dividend